← Back to Search

Dental Implant

Immediate placement non-occlusal loading molar implant (Straumann BLX 6.5mm) for Immediate Placement of Straumann BLX Implants in Molar Extraction Sockets

Phase 2
Waitlist Available
Led By Ahmad KutKut, DDS, MS
Research Sponsored by Ahmad Kutkut
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

This trial will compare the success of dental implants placed immediately after a tooth is extracted to those placed delayed (at least 12 weeks post-extraction).

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
3D Printed Models Assessment
Clinical Examination: Implant Success and Failure Criteria
Osstell Value Assessment
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: test groupExperimental Treatment1 Intervention
The test group will receive immediate molar implant placement in fresh extraction socket with nonocclusal loading immediate provisionalization (Straumann BLX 6.5mm).
Group II: Control groupActive Control1 Intervention
The control group will receive delayed molar implant placement at least 12 weeks post molar extraction with nonocclusal loading immediate provisionalization (Straumann BLX 5.0mm).

Find a Location

Who is running the clinical trial?

Straumann USAUNKNOWN
Ahmad KutkutLead Sponsor
1 Previous Clinical Trials
11 Total Patients Enrolled
Ahmad KutKut, DDS, MSPrincipal InvestigatorUniversity of Kentucky

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Could I potentially qualify for enrollment in this experiment?

"To qualify for this interventional trial, individuals must be between 22 and 78 years of age with straumann blx implants placed in recently extracted molar sockets. A maximum of 30 participants will be accepted."

Answered by AI

Is the Straumann BLX 6.5mm Immediate placement non-occlusal loading molar implant compliant with FDA regulations?

"The team at Power gave Immediate placement non-occlusal loading molar implant (Straumann BLX 6.5mm) a score of 2, since there is some evidence in support of its safety but no efficacy data has been established yet."

Answered by AI

Is this clinical trial recruiting volunteers at the present time?

"Clinicaltrials.gov indicates that this clinical trial is not presently recruiting patients. The initial posting was on August 1st 2023 and the page has been updated as recently as October 31st 2022. However, there are still additional studies seeking patient participation at present."

Answered by AI

Does this research include senior citizens in its participant pool?

"The age range for potential candidates is 22 years and older, up to 78."

Answered by AI

Who else is applying?

What state do they live in?
Tennessee
Texas
New York
Other
How old are they?
18 - 65
What site did they apply to?
University of Kentucky
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
0
Recent research and studies
clinicaltrials.govStudy
Immediate vs Delayed Placement of Straumann BLX Implants in Molar Extraction Sockets
Ahmad Kutkut 2023. "Immediate vs Delayed Placement of Straumann BLX Implants in Molar Extraction Sockets". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04327284.
~0 spots leftby Jun 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top